Ability and willingness to utilize telemedicine among rheumatology patients—a cross-sectional survey

Kong, Steve S; Rojas, Lilian A Otalora; Ashour, Amnie; Robinson, Michael; Hosterman, Tyler; Bhanusali, Neha

doi:10.1007/s10067-021-05759-8

Cited by 24 publications

(22 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The younger groups tend to be more familiar with the newer technology, which results in them being more aware of the newer services that have been offered. In another study that was conducted in the United States, older people were not likely to be interested in using telemedicine services due to their lack of belief that the health care purpose can be achieved at a distance ( 23 ).…”

Section: Discussionmentioning

confidence: 99%

Knowledge, Perception, and Willingness to Use Telepharmacy Among the General Population in Indonesia

Tjiptoatmadja

Alfian

2022

Front. Public Health

View full text Add to dashboard Cite

IntroductionCOVID-19 emerged as a pandemic in early 2020. Various steps were taken in an attempt to decrease the spread, which resulted in limited mobility. As people were dissuaded from going out, multiple numbers of digitalized pharmacy services arose to fulfill people's needs for medicine. The objective of this study was to assess knowledge, perception, and willingness to use telepharmacy services and the affecting factors among the general population in Indonesia.Patients and MethodsA cross-sectional study was conducted with the inclusion criteria of Indonesian citizenship, living in Indonesia, and agreement to participate. Details of demographic characteristics, knowledge and perception of telepharmacy services and willingness to use them were collected using an online questionnaire that was adapted from a previous study. The results were analyzed using a descriptive analysis method. The associations between demographic characteristics and knowledge, perception, and willingness to use telepharmacy services were tested with the Mann–Whitney U Test.ResultsOf 203 participants participated in this study, 51% of them had heard about telepharmacy. Over 98% of the participants had a positive perception of telepharmacy services. The majority of those who had never used it were willing to try telepharmacy services in the future. Age and educational level were significantly associated with knowledge of telepharmacy services. No associations were observed between demographic characteristics and perception and willingness to use telepharmacy services.ConclusionsGeneral population in Indonesia had a fair knowledge, a positive perception, and were willing to use telepharmacy services. Interventions to increase knowledge of telepharmacy in Indonesia need to target older adults and people who are less educated.

show abstract

Section: Discussionmentioning

confidence: 99%

Knowledge, Perception, and Willingness to Use Telepharmacy Among the General Population in Indonesia

Tjiptoatmadja

Alfian

2022

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…Before the pandemic, home-based automated systems and web-based services were developed to encompass telemonitoring, teleconsulting, and tele-education for patients with IBD [ 104 ], with patient acceptance of virtual monitoring increasing in rheumatology and gastroenterology settings [ 104 , 105 ]. One systematic review found telerheumatology to be met with high rates of patient satisfaction [ 106 ], although potential barriers, such as accessibility and acceptance of telemedicine by older patients, must be considered [ 107 ]. Indeed, rheumatology patients receiving SC biologics have been managed successfully via telemedicine during the pandemic [ 2 , 108 ].…”

Section: Clinical Implications Of Sc Infliximab In the Covid-19 Pandemic Era And Beyondmentioning

confidence: 99%

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

et al. 2022

View full text Add to dashboard Cite

Graphical Abstract The coronavirus disease 2019 (COVID-19) pandemic has prompted significant changes in patient care in rheumatology and gastroenterology, with clinical guidance issued to manage ongoing therapy while minimising the risk of nosocomial infection for patients and healthcare professionals (HCPs). Subcutaneous (SC) formulations of biologics enable patients to self-administer treatments at home; however, switching between agents may be undesirable. CT-P13 SC is the first SC formulation of infliximab that received regulatory approval and may be termed a biobetter as it offers significant clinical advantages over intravenous (IV) infliximab, including improved pharmacokinetics and a convenient mode of delivery. Potential benefits in terms of reduced immunogenicity have also been suggested. With a new SC formulation, infliximab provides an additional option for dual formulation, which enables patients to transition from IV to SC administration route without changing agent. Before COVID-19, clinical trials supported the efficacy and safety of switching from IV to SC infliximab for patients with rheumatoid arthritis and inflammatory bowel disease (IBD), and SC infliximab may have been selected on the basis of patient and HCP preferences for SC agents. During the pandemic, patients with rheumatic diseases and IBD have successfully switched from IV to SC infliximab, with some clinical benefits and high levels of patient satisfaction. As patients switched to SC therapeutics, the reduction in resource requirements for IV infusion services may have been particularly welcome given the pandemic, facilitating reorganisation and redeployment in overstretched healthcare systems, alongside pharmacoeconomic benefits and a reduction in exposure to nosocomial infection. Telemedicine and contactless healthcare have been pushed to the forefront during the pandemic, and a lasting shift towards remote patient management and community/home-based drug administration is anticipated. SC infliximab supports the implementation of this paradigm for future improvements of healthcare value delivered. The accumulation of real-world data during the pandemic supports the high level of confidence, with patients, physicians, and healthcare systems benefitting from its uptake.

show abstract

“…A video connection could also be used in combination with patient portals and access to EHRs [ 42 ] and different devices and apps [ 125 ]. Video consultations offer possibilities for first and follow-up visits at the clinic [ 46 , 49 , 53 ], for peri- and postoperative sessions [ 125 ] and for medication and psychotherapy sessions [ 59 ].…”

Section: Resultsmentioning

confidence: 99%

The Use of Digital Health Services Among Patients and Citizens Living at Home: Scoping Review

Rosenlund¹,

Kinnunen²,

Saranto³

2023

J Med Internet Res

View full text Add to dashboard Cite

Background The development of digital health services reflects not only the technical development of services but also a change in attitude and the way of thinking. It has become a cornerstone for engaging and activating patients and citizens in health management while living at home. Digital health services are also aimed at enhancing the efficiency and quality of services, while simultaneously providing services more cost-effectively. In 2020, the COVID-19 pandemic accelerated worldwide the development and use of digital services in response to requirements for social distancing and other regulations. Objective The aim of this review is to identify and summarize how digital health services are being used among patients and citizens while living at home. Methods The Joanna Briggs Institute (JBI) methodology for scoping reviews was used as guidance. A search conducted in 3 databases (CINAHL, PubMed, Scopus) resulted in 419 papers. The reporting was conducted by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping review (PRISMA-ScR), and the analysis of the included papers was performed using a framework consisting of 5 clusters describing the use of digital health services. After screening and excluding papers that did not match the inclusion criteria, 88 (21%) papers from 2010 to 2022 were included in the final analysis. Results Results indicated that digital health services are used in different situations and among different kinds of populations. In most studies, digital health services were used in the form of video visits or consultations. The telephone was also used regularly for consultations. Other services, such as remote monitoring and transmitting of recorded information and the use the of internet or portals for searching information, were observed as well. Alerts, emergency systems, and reminders were observed to offer possibilities of use, for example, among older people. The digital health services also showed to have potential for use in patient education. Conclusions The development of digital services reflects a shift toward the provision of care regardless of time and place. It also reflects a shift toward emphasis on patient-centered care, meaning activating and engaging patients in their own care as they use digital services for various health-related purposes. Despite the development of digital services, many challenges (eg, adequate infrastructure) still prevail worldwide.

show abstract

Ability and willingness to utilize telemedicine among rheumatology patients—a cross-sectional survey

Cited by 24 publications

References 14 publications

Knowledge, Perception, and Willingness to Use Telepharmacy Among the General Population in Indonesia

Knowledge, Perception, and Willingness to Use Telepharmacy Among the General Population in Indonesia

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

The Use of Digital Health Services Among Patients and Citizens Living at Home: Scoping Review

Contact Info

Product

Resources

About